Vistagen Therapeutics, Inc. (VTGN): EPS (Basic)
-$1.83
Year ended 2026-03-31
| Period ended | EPS (Basic) | Change YoY | Source filing |
|---|---|---|---|
| 2026-03-31 | -$1.83 | n/m | 2026-06-15, From 2025-04-01 |
| 2025-03-31 | -$1.67 | n/m | 2026-06-15, From 2024-04-01 |
| 2024-03-31 | -$1.52 | n/m | 2025-06-17, From 2023-04-01 |
| 2023-03-31 | -$8.51 | n/m | 2024-06-11, From 2022-04-01 |
| 2022-03-31 | -$7.38 | n/m | 2023-06-28, From 2021-04-01 |
| 2021-03-31 | -$0.49 | n/a | 2022-06-23, From 2020-04-01 |
| No annual figure between 2016-03-31 and 2021-03-31. | |||
| 2016-03-31 | -$29.08 | n/m | 2016-06-24, From 2015-04-01 |
| 2015-03-31 | -$10.53 | n/m | 2016-06-24, From 2014-04-01 |
| 2014-03-31 | -$2.70 | n/m | 2015-06-29, From 2013-04-01 |
| 2013-03-31 | -$1.27 | n/a | 2014-06-25, From 2012-04-01 |
EPS (Basic) at similar companies
| Company | Year ended | EPS (Basic) | Change YoY |
|---|---|---|---|
| Vistagen Therapeutics, Inc. (VTGN) | 2026-03-31 | -$1.83 | n/m |
| IGC Pharma, Inc. (IGC) | 2025-03-31 | -$0.09 | n/m |
| Longeveron Inc. (LGVN) | 2025-12-31 | -$1.29 | n/m |
| Neuphoria Therapeutics Inc. (NEUP) | 2026-06-30 | -$3.06 | n/m |
| Northwest Biotherapeutics Inc (NWBO) | 2025-12-31 | -$0.04 | n/m |
| Avenue Therapeutics, Inc. (ATXI) | 2025-12-31 | -$0.93 | n/m |
| China SXT Pharmaceuticals, Inc. (SXTC) | 2026-03-31 | -$9.13 | n/m |
| Bespoke Extracts, Inc. (BSPK) | 2024-12-31 | -$0.10 | n/m |
| NRX Pharmaceuticals, Inc. (NRXP) | 2025-12-31 | -$1.34 | n/m |
Compare VTGN, IGC, LGVN, NEUP side by side · Screen every company in Pharmaceutical Preparations ↗